Plug Power Inc vs uniQure N.V. Ordinary Shares — how do they compare? Plug Power Inc trades at $1.41 (market cap $2.18B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: Plug Power Inc is the larger of the two by market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Plug Power Inc for 42 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| PLUG | QURE | |
|---|---|---|
Market Cap | $2.18B | $1.48B |
Volume | 58,569,311 | 2,488,780 |
Sector | Industrials | Health |
52-Week High | $4.14 | $70.59 |
52-Week Low | $1.45 | $9.03 |
Typical Hold Time | 42 Days | 0 Days |
Enterprise Value | $3.05B | $728.62M |
Signals from Pluang's Aura AI — not financial advice
Plug Power (PLUG) trades at $1.56, down 3.7% with a bearish technical outlook. The company shows persistent financial challenges with negative gross margins (-18.55%) and net income margin (-220.59%), though revenue grew to $710M in 2025. Recent news highlights strategic partnerships including a 280 MW electrolyzer agreement with Arcadia eFuels, positioning PLUG in the green hydrogen ecosystem. Cash flow remains negative with -$47M net cash flow in 2025, requiring ongoing financing.
Outlook remains speculative with significant execution risks despite analyst consensus of $2.65 price target (44.7% buy rating). The stock faces substantial operational losses, high cash burn, and competitive pressure in clean energy. Upside depends on successful hydrogen infrastructure deployment and margin improvement, while downside risks include funding challenges and delayed profitability.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →